Gynecologic interventions during adjuvant therapy with anastrozole or tamoxifen: results from the ATAC trial

被引：0
|
作者：
Duffy, SR
Distler, W
机构：
[1] St James Univ Hosp, Leeds, W Yorkshire, England
[2] Univ Klinikum Carl Gustav Carus, Dresden, Germany
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2005年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S103 / S103
页数：1
相关论文
共 50 条
  • [1] A lower incidence of gynecologic adverse events and interventions with anastrozole than with tamoxifen in the ATAC trial
    Duffy, Sean R.
    Distler, Wolfgang
    Howell, Anthony
    Cuzick, Jack
    Baum, Michael
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2009, 200 (01) : 80.e1 - 80.e7
  • [2] Impact of chemotherapy regimens prior to endocrine therapy - Results from the ATAC (anastrozole and tamoxifen, alone or in combination) trial
    Buzdar, Aman U.
    Guastalla, Jean-Paul
    Nabholtz, Jean-Marc
    Cuzick, Jack
    CANCER, 2006, 107 (03) : 472 - 480
  • [3] Effect of anastrozole on bone mineral density and bone fractures: results from the 'Arimidex' (anastrozole), Tamoxifen, Alone or in Combination (ATAC) trial
    Coleman, R.
    EJC SUPPLEMENTS, 2004, 2 (03): : 140 - 140
  • [4] Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial
    Baum, M
    Buzdar, AU
    Cuzick, J
    Forbes, J
    Houghton, J
    Klijn, JGM
    Sahmoud, T
    LANCET, 2002, 359 (9324): : 2131 - 2139
  • [5] Impact of age on the gynecologic adverse event (AE) profile of anastrozole (A) or tamoxifen (T) in the ATAC ('Arimidex', Tamoxifen, Alone or in Combination) trial.
    Distler, W
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 69S - 69S
  • [6] Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women:: a sub-protocol of the 'Arimidex™ and Tamoxifen Alone or in Combination' (ATAC) trial
    Baum, M
    Dowsett, M
    Coibion, M
    Bianco, AR
    Cuzick, J
    George, WD
    Gray, J
    Howell, A
    Houghton, J
    Williams, N
    Sloane, J
    Tobias, J
    Buzdar, A
    Anderson, MD
    Jackson, I
    Sahmoud, T
    Gallagher, J
    Webster, A
    Gangji, D
    Petrakova, K
    Konopasek, B
    Mares, P
    Vodvarka, P
    Alcazar, A
    Campos, O
    Maxwell, A
    Goedhals
    Hacking, D
    Landers, G
    Smith, L
    Vorobiof, DA
    Werner, ID
    Blamey, R
    Coleman, R
    Grieve, RJ
    Hickish, T
    Howell, A
    Nicholls, JC
    Nicholson, S
    Raymond, S
    Salman, A
    Blum, J
    Clark, R
    Lyss, A
    Miletello, G
    Sternberg, J
    Forbes, J
    Coibion, M
    Nabholtz, JM
    Guastalla, JP
    BRITISH JOURNAL OF CANCER, 2001, 85 (03) : 317 - 324
  • [7] Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women: a sub-protocol of the ‘Arimidex™ and Tamoxifen Alone or in Combination’ (ATAC) trial
    British Journal of Cancer, 2001, 85 : 317 - 324
  • [8] Long-term comparison of anastrozole versus tamoxifen: Results from LATTE/ATAC
    Cuzick, J.
    Sestak, I.
    Bianco, A.
    Strobbe, L.
    Bergh, J.
    Hanusch, C.
    Neven, P.
    Dowsett, M.
    Forbes, J. F.
    Buzdar, A.
    Smith, R.
    Howell, A.
    CANCER RESEARCH, 2017, 77
  • [9] Effect of anastrozole on bone mineral density: 5-year results of the 'Arimidex' (anastrozole), tamoxifen, alone or in combination (ATAC) trial
    不详
    CALCIFIED TISSUE INTERNATIONAL, 2006, 78 : S25 - S25
  • [10] Effect of anastrozole on bone mineral density: 2-year results of the 'arimidex' (anastrozole), tamoxifen, alone or in combination (ATAC) trial
    Howell, A
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S27 - S27
12345